This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Coleus forskohlii is a medicinal plant from the Lamiaceae family primarily known for producing forskolin, a compound used in the treatment of glaucoma, asthma, and heart ailments [PMID:31989223, PMID:38623169].
Background
Coleus forskohlii (also known as Plectranthus barbatus) is a tropical perennial herb of Indian origin [PMID:31803808, PMID:38623169]. It is the sole natural source of the labdane-type diterpenoid forskolin, which is concentrated in the cork tissue of its tuberous roots [PMID:33928347, PMID:38623169].
Traditional uses
Traditional uses include the treatment of heart diseases, abdominal colic, respiratory disorders, intestinal disturbance, liver fatigue, and certain nervous system disorders [PMID:20186655, PMID:26130934].
Active compounds
The primary active compound is forskolin (a labdane-type diterpenoid) [PMID:23023353, PMID:33928347]. Other constituents include abietane diterpenoids, essential oils, and various polyphenolic compounds such as gallic acid [PMID:20186655, PMID:31547727, PMID:36558119].
Mechanism of action
Forskolin acts by stimulating the enzyme adenylate cyclase, which increases the concentration of cyclic adenosine monophosphate (cAMP) [PMID:23023353, PMID:25726172, PMID:38623169]. In the eye, this activates the ciliary epithelium to reduce aqueous humor inflow, thereby decreasing intraocular pressure [PMID:23023353].
Clinical evidence
Evidence BHypertension
A clinical study in a geriatric population (50-80 years) found that treatment with Coleus forskohlii (as Ghana vati or Churna tablets) resulted in good outcomes regarding systolic and diastolic blood pressure [PMID:22131759]
Evidence CGlaucoma
Topical application of forskolin is capable of reducing intraocular pressure in humans, rabbits, and monkeys [PMID:23023353]
Evidence DCataract
In a rat model, hydroalcoholic leaf-extract fractions of C. forskohlii reduced mean arterial pressure and glucose levels in a dose-dependent manner, showing protective effects against fructose-induced cataract [PMID:31547727]
Safety & adverse effects
Coleus forskohlii is reported to be well tolerated as a supplement [PMID:30000934]. However, a cytogenetic assay in Allium cepa suggested that forskolin may cause genotoxic effects, including increased chromosome aberrations and reduced mitotic index at concentrations of 5-100 µM [PMID:25726172].
Drug interactions
Forskolin may act synergistically with epinephrine, ephedrine, and pseudoephedrine [PMID:23023353]. It may enhance the effects of anti-clotting medications such as warfarin, clopidogrel, aspirin, and enoxaparin [PMID:23023353].
Evidence summary
Evidence consists primarily of narrative reviews and laboratory/animal studies (Level C/D), with limited clinical data on hypertension (Level B).
PubMed sources
1.PMID: 30000934 (2006) — Coleus forskohlii. Monograph. · Alternative medicine review : a journal of clinical therapeutic
2.PMID: 23023353 (2012) — Forskolin: upcoming antiglaucoma molecule. · Journal of postgraduate medicine
3.PMID: 33928347 (2021) — Progress in heterologous biosynthesis of forskolin. · Journal of industrial microbiology & biotechnology
4.PMID: 31989223 (2020) — Coleus forskohlii: advancements and prospects of in vitro biotechnology. · Applied microbiology and biotechnology
5.PMID: 22131759 (2011) — Clinical efficacy of Coleus forskohlii (Willd.) Briq. (Makandi) in hypertension of geriatric population.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 38623169 (2024) — Biotechnological interventions for the production of forskolin, an active compound from the medicinal plant, Coleus forskohlii. · Physiology and molecular biology of plants : an international journal of functional plant biology
7.PMID: 20186655 (2010) — Plectranthus barbatus: a review of phytochemistry, ethnobotanical uses and pharmacology - part 2. · Planta medica
8.PMID: 36558119 (2022) — Bioactive Properties of Extracts from Plectranthus barbatus (Coleus forskohlii) Roots Received Using Various Extraction Methods. · Molecules (Basel, Switzerland)
9.PMID: 31803808 (2019) — Characterization of cucumber mosaic virus infecting coleus (Plectranthus barbatus) in Karnataka. · Virusdisease
10.PMID: 25726172 (2015) — Forskolin: genotoxicity assessment in Allium cepa. · Mutation research. Genetic toxicology and environmental mutagenesis
11.PMID: 26130934 (2015) — Extraction and elemental analysis of Coleus forskohlii extract. · Pharmacognosy research
12.PMID: 31547727 (2022) — Protective effect of Coleus forskohlii leaf-extract compound on progression of cataract against Fructose-Induced experimental cataract in rats. · Drug and chemical toxicology